Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Seth M Steinberg

Showing results (261-270 of 481) with videos related to

Pageof 49
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 17, 2013
Electrocardiographic studies of romidepsin demonstrate its safety and identify a potential role for K(ATP) channelAnne M Noonan, Robin A Eisch, David J Liewehr, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 4, 2019
Phase I/II Study of the Mesothelin-targeted Immunotoxin LMB-100 with Nab-Paclitaxel for Patients with Advanced Pancreatic AdenocarcinomaChristine Alewine, Mehwish Ahmad, Cody J Peer, et al.
The Annals of Thoracic Surgery|December 30, 2020
Characteristics of Matriculants to Thoracic Surgery Residency Training ProgramsJustin A Drake, Laurence P Diggs, Sean P Martin, et al.
Bone Marrow Transplantation|September 8, 2023
Metabolic syndrome prevalence and impact on outcomes in patients with chronic graft-versus-host diseaseAaron T Zhao, Filip Pirsl, Seth M Steinberg, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 18, 2004
Allogeneic lymphocytes induce tumor regression of advanced metastatic breast cancerMichael R Bishop, Daniel H Fowler, Donna Marchigiani, et al.
The Journal of Urology|February 16, 2005
A randomized, phase II trial of ketoconazole plus alendronate versus ketoconazole alone in patients with androgen independent prostate cancer and bone metastasesWilliam D Figg, Yinong Liu, Philip Arlen, et al.
Investigational New Drugs|March 22, 2016
Randomized phase II trial of cyclophosphamide and the oral poly (ADP-ribose) polymerase inhibitor veliparib in patients with recurrent, advanced triple-negative breast cancerShivaani Kummar, James L Wade, Amit M Oza, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 4, 2016
Phase II Study of Alemtuzumab (CAMPATH-1) in Patients with HTLV-1-Associated Adult T-cell Leukemia/lymphomaKamal Sharma, John E Janik, Deirdre O'Mahony, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 18, 2014
Profound prevention of experimental brain metastases of breast cancer by temozolomide in an MGMT-dependent mannerDiane Palmieri, Renata Duchnowska, Stephan Woditschka, et al.
BJU International|April 18, 2007
Pre-clinical and clinical evaluation of estramustine, docetaxel and thalidomide combination in androgen-independent prostate cancerWilliam D Figg, Haiqing Li, Tristan Sissung, et al.
Pageof 49

Showing results (261-270 of 481) with videos related to

Sort By:
Pageof 49
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 17, 2013
Electrocardiographic studies of romidepsin demonstrate its safety and identify a potential role for K(ATP) channelAnne M Noonan, Robin A Eisch, David J Liewehr, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 4, 2019
Phase I/II Study of the Mesothelin-targeted Immunotoxin LMB-100 with Nab-Paclitaxel for Patients with Advanced Pancreatic AdenocarcinomaChristine Alewine, Mehwish Ahmad, Cody J Peer, et al.
The Annals of Thoracic Surgery|December 30, 2020
Characteristics of Matriculants to Thoracic Surgery Residency Training ProgramsJustin A Drake, Laurence P Diggs, Sean P Martin, et al.
Bone Marrow Transplantation|September 8, 2023
Metabolic syndrome prevalence and impact on outcomes in patients with chronic graft-versus-host diseaseAaron T Zhao, Filip Pirsl, Seth M Steinberg, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 18, 2004
Allogeneic lymphocytes induce tumor regression of advanced metastatic breast cancerMichael R Bishop, Daniel H Fowler, Donna Marchigiani, et al.
The Journal of Urology|February 16, 2005
A randomized, phase II trial of ketoconazole plus alendronate versus ketoconazole alone in patients with androgen independent prostate cancer and bone metastasesWilliam D Figg, Yinong Liu, Philip Arlen, et al.
Investigational New Drugs|March 22, 2016
Randomized phase II trial of cyclophosphamide and the oral poly (ADP-ribose) polymerase inhibitor veliparib in patients with recurrent, advanced triple-negative breast cancerShivaani Kummar, James L Wade, Amit M Oza, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 4, 2016
Phase II Study of Alemtuzumab (CAMPATH-1) in Patients with HTLV-1-Associated Adult T-cell Leukemia/lymphomaKamal Sharma, John E Janik, Deirdre O'Mahony, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 18, 2014
Profound prevention of experimental brain metastases of breast cancer by temozolomide in an MGMT-dependent mannerDiane Palmieri, Renata Duchnowska, Stephan Woditschka, et al.
BJU International|April 18, 2007
Pre-clinical and clinical evaluation of estramustine, docetaxel and thalidomide combination in androgen-independent prostate cancerWilliam D Figg, Haiqing Li, Tristan Sissung, et al.
Pageof 49